The past years have established the importance of estrogens in the pathophysiology of
schizophrenia and have shown its relevance to clinical practice through its influence on …

Dopamine's ability to oxidize to aminochrome explains why this molecule may be a
neurotoxic compound that induces toxicity in both cell lines and animal models …

The commentary is an invited brief about my contribution to Psychiatry Research. My work
has built on the “estrogen hypothesis”, as stated by Hafner, Riecher-Rossler and Seeman in …

Parkinson's Disease (PD) has witnessed an alarming rise in prevalence, highlighting the
suboptimal nature of early diagnostic and therapeutic strategies. To address this issue …

Cognitive dysfunctions are core-enduring symptoms of schizophrenia, with important sex-
related differences. Genetic variants of the DTBPN1 gene associated with reduced …

Postmortem and neuroimaging studies show low levels of cortical muscarinic M1 receptors
(CHRM1) in patients with schizophrenia which is significant because CHRM signalling has …

Methamphetamine use disorder (MAUD) can substantially jeopardize public security due to
its high‐risk social psychology and behaviour. Given that the dopamine reward system is …

It has been postulated that common molecular changes resulting from treatment with
antipsychotic drugs are involved in their therapeutic mechanisms of action. There are …

It is suggested studying phenotypes within the syndrome of schizophrenia will accelerate
understanding the complex molecular pathology of the disorder. Supporting this hypothesis …

Radiotherapy is used as definitive treatment in approximately two-thirds of all cancers.
However, like any treatment, radiation has significant acute and long-term side effects …